
Sign up to save your podcasts
Or
An interview with Dr. Kala Visvanathan from Sidney Kimmel Comprehensive Cancer Center, and Johns Hopkins Bloomberg School of Public Health on the guideline update. This update adds anastrozole to the options of pharmacologic interventions for breast cancer risk reduction based on recent practice changing data. Read the full guideline at www.asco.org/breast-cancer-guidelines.
4.5
3131 ratings
An interview with Dr. Kala Visvanathan from Sidney Kimmel Comprehensive Cancer Center, and Johns Hopkins Bloomberg School of Public Health on the guideline update. This update adds anastrozole to the options of pharmacologic interventions for breast cancer risk reduction based on recent practice changing data. Read the full guideline at www.asco.org/breast-cancer-guidelines.
130 Listeners
324 Listeners
17 Listeners
533 Listeners
38 Listeners
2,620 Listeners
492 Listeners
57 Listeners
3,322 Listeners
43 Listeners
186 Listeners
349 Listeners
169 Listeners
39 Listeners
133 Listeners